grant

Does pneumococcal vaccination protect against cardiovascular disease? A randomised placebo-controlled double blind trial [ 2014 - 2019 ]

Also known as: Does pneumococcal vaccination protect against cardiovascular disease?

Funded by National Health and Medical Research Council
Managed by The University of Newcastle
Managed by University of Newcastle
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1062563]

Researchers: Prof John Attia (Principal investigator) ,  A/Pr Jonathan Sturm ,  A/Pr Mark Mcevoy ,  Dr Alexis Hure ,  Prof Andrew Tonkin
View all 10 related researchers

Brief description Australian researchers have set up a novel multi-centre trial to investigate the effects of the pneumococcal vaccination in reducing heart attacks and stroke. People aged 55 to 61 from 6 sites around Australia will be invited to participate in the study. The selected participants will attend a clinic in their area and will be randomly given the pneumococcal vaccine or a placebo vaccine. Outcomes on the expected 6000 participants will be ascertained by health record linkage with government databases after 4 years.

Funding Amount $AUD 1,849,245.31

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Medical and Health Sciences | Public Health and Health Services | Preventive Medicine | ageing population | atherosclerosis | cardiovascular disease prevention | hospital morbidity | immune protection | immunisation | longevity | plaque | stroke prevention | vaccination |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA